Royal Bank of Canada’s ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) ECTE Stock Holding History

Royal Bank of Canada’s Portfolio ECTE Stock Details ECTE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-20	Closed	–	–	6955
2015 Q4	$0	Hold	20	–	–	﹤0.01%	7083
2015 Q3	$0	Hold	20	–	–	﹤0.01%	6945
2015 Q2	$0	Hold	20	–	–	﹤0.01%	6862
2015 Q1	$0	Hold	20	–	–	﹤0.01%	6625
2014 Q4	$0	Hold	20	–	–	﹤0.01%	6455
2014 Q3	$0	Hold	20	–	–	﹤0.01%	6284
2014 Q2	$0	Sell	20 -4	-17%	-$10	﹤0.01%	6318
2014 Q1	$0	Sell	24 -6,000	-100%	-$19.8K	﹤0.01%	6325
2013 Q4	$19K	Buy	6,024 +6,000	+25,000%	+$16.7K	﹤0.01%	5283
2013 Q3	$0	Hold	24	–	–	﹤0.01%	6401
2013 Q2	$0	Buy	+24	New	+$126	﹤0.01%	5892

Other funds holding ECTE

Platinum Management New York $16.4M AUM 30.38% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

EWM

Edge Wealth Management New York $594M AUM 24.92% 1-Year Est. Return

Royal Bank of Canada's ECTE Position: Q1 2016 in Review

Royal Bank of Canada sold out of ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) (ECTE) in Q1 2016, closing a stake of 20 shares.

Royal Bank of Canada first reported a position in ECTE in Q2 2013 and held it in 11 quarters. The position peaked at $19K in Q4 2013. 15 funds tracked by Wall St. Rank hold ECTE as of Q1 2016.

Royal Bank of Canada reported no remaining ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) position as of Q1 2016 after selling out during the quarter.
Royal Bank of Canada sold 20 ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) shares in Q1 2016.
Royal Bank of Canada first reported a position in ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) in Q2 2013 and held it in 11 quarters.
Royal Bank of Canada's ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) position peaked at $19K in Q4 2013.
15 funds tracked by Wall St. Rank held ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) as of Q1 2016.

Based on Royal Bank of Canada's 13F filing for Q1 2016, filed 16 May 2016.